291 related articles for article (PubMed ID: 28285612)
1. Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy.
Cascella M; Muzio MR
J Integr Med; 2017 Mar; 15(2):77-87. PubMed ID: 28285612
[TBL] [Abstract][Full Text] [Related]
2. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
3. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.
Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T; Kono T
Int J Clin Oncol; 2011 Aug; 16(4):322-7. PubMed ID: 21258836
[TBL] [Abstract][Full Text] [Related]
4. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Hoshino N; Ganeko R; Hida K; Sakai Y
Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
[TBL] [Abstract][Full Text] [Related]
5. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
[TBL] [Abstract][Full Text] [Related]
6. Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.
Mizuno K; Kono T; Suzuki Y; Miyagi C; Omiya Y; Miyano K; Kase Y; Uezono Y
J Pharmacol Sci; 2014; 125(1):91-8. PubMed ID: 24784702
[TBL] [Abstract][Full Text] [Related]
7. Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula "Goshajinkigan".
Toume K; Hou Z; Yu H; Kato M; Maesaka M; Bai Y; Hanazawa S; Ge Y; Andoh T; Komatsu K
J Nat Med; 2019 Sep; 73(4):761-768. PubMed ID: 31190267
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.
Oki E; Emi Y; Kojima H; Higashijima J; Kato T; Miyake Y; Kon M; Ogata Y; Takahashi K; Ishida H; Saeki H; Sakaguchi Y; Yamanaka T; Kono T; Tomita N; Baba H; Shirabe K; Kakeji Y; Maehara Y
Int J Clin Oncol; 2015 Aug; 20(4):767-75. PubMed ID: 25627820
[TBL] [Abstract][Full Text] [Related]
9. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.
Hoshino N; Hida K; Ganeko R; Sakai Y
Int J Colorectal Dis; 2017 May; 32(5):737-740. PubMed ID: 27889823
[TBL] [Abstract][Full Text] [Related]
10. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
Hirayama Y; Yoshida Y; Mori M; Tamura K
Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
[TBL] [Abstract][Full Text] [Related]
11. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
[TBL] [Abstract][Full Text] [Related]
12. Three Cases of Chemotherapy-induced Peripheral Neuropathy Successfully Treated With Therapy Based on Kampo Diagnosis.
Yoshiro H; Sekiya N; Chino A; Ueda K; Okamoto H; Namiki T
Altern Ther Health Med; 2011; 17(5):26-30. PubMed ID: 22314673
[TBL] [Abstract][Full Text] [Related]
13. Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy.
Samuels N; Ben-Arye E
Curr Oncol Rep; 2020 Feb; 22(3):23. PubMed ID: 32048067
[TBL] [Abstract][Full Text] [Related]
14. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
[TBL] [Abstract][Full Text] [Related]
15. The Kampo medicine Goshajinkigan prevents neuropathy in breast cancer patients treated with docetaxel.
Abe H; Kawai Y; Mori T; Tomida K; Kubota Y; Umeda T; Tani T
Asian Pac J Cancer Prev; 2013; 14(11):6351-6. PubMed ID: 24377531
[TBL] [Abstract][Full Text] [Related]
16. [Current Status of Japanese Traditional Medicine 'Kampo' in Chemotherapy].
Nagata N
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2423-9. PubMed ID: 26809300
[TBL] [Abstract][Full Text] [Related]
17. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats.
Kono T; Suzuki Y; Mizuno K; Miyagi C; Omiya Y; Sekine H; Mizuhara Y; Miyano K; Kase Y; Uezono Y
Sci Rep; 2015 Nov; 5():16078. PubMed ID: 26542342
[TBL] [Abstract][Full Text] [Related]
19. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
Ushio S; Kawashiri T; Egashira N
Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
[No Abstract] [Full Text] [Related]
20. Goshajinkigan for Low Back Pain: An Observational Study.
Hamaguchi T; Yoshino T; Horiba Y; Watanabe K
J Altern Complement Med; 2017 Mar; 23(3):208-213. PubMed ID: 27991830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
